乳腺癌血管化中内乳动脉的主导作用:动态MRI研究肿瘤诱导的动脉重塑
本研究回顾性分析197例乳腺MRI患者(163例新诊断乳腺癌,34例良性病变),测量病灶侧和对侧内乳动脉(IMA)及胸外侧动脉(LTA)直径。结果显示恶性组病灶侧IMA和LTA直径均显著大于对侧,且IMA相对增粗程度在所有病灶位置均大于LTA;良性组未见单侧血管不对称或病灶侧动脉增粗。研究表明IMA主导的血管重塑模式与恶性肿瘤相关,但对预测肿瘤侵袭性或淋巴结状态价值有限。
要点
- 乳腺癌病灶侧内乳动脉(IMA)较对侧显著增粗,且相对增粗程度大于胸外侧动脉,提示IMA主导的血管重塑
- 良性病变不出现单侧血管不对称或病灶侧动脉增粗,此现象可作为恶性病变的辅助鉴别指标之一
- 血管增粗现象对预测肿瘤侵袭性或淋巴结状态价值有限,阅片时不宜据此推断预后
核心结论
- 乳腺癌患者病灶侧IMA和LTA均显著增粗,且IMA相对增粗程度在所有病灶位置(外侧、内侧、中央)均显著大于LTA(p < 0.001),支持恶性肿瘤相关的IMA主导血管重塑模式
- 良性乳腺病变患者未观察到单侧血管不对称或病灶侧动脉增粗,提示此现象为恶性肿瘤特异性的肿瘤相关血管反应
- 该血管增粗征象对预测肿瘤侵袭性或淋巴结状态价值有限
研究设计与样本
- 回顾性单中心研究,纳入197例乳腺MRI患者(163例新诊断、组织病理学证实的乳腺癌患者,34例良性乳腺病变作为对照组)
- 测量病灶侧与对侧IMA和LTA直径及扩张比值,按乳腺内病灶位置(外侧、内侧、中央)和临床病理因素进行分析
- 血管直径在增强后动脉期早期原始轴位图像(第2-3个动态序列)上测量,由两名不同年资放射科医生(高年资乳腺放射科医生和5年级住院医师)独立测量,互不知晓对方结果
- 采用层间相关系数(ICC)评估观察者间一致性
关键影像表现/征象
- 恶性组病灶侧IMA中位直径为3.4 mm(范围2.6-4.4),对侧为2.5 mm(范围2.0-3.1),病灶侧显著增大
- 恶性组病灶侧LTA中位直径为2.3 mm(范围1.8-2.8),对侧为2.0 mm(范围1.7-2.5),病灶侧显著增大
- 良性组未见侧别血管不对称或病灶侧动脉增粗,血管直径比值接近1
- IMA测量观察者间一致性优秀(ICC = 0.92;95% CI,0.88-0.95),LTA测量一致性良好至优秀(ICC = 0.87;95% CI,0.82-0.91)
诊断标准与关键数值
- 病灶侧IMA直径大于对侧(如中位数3.4 mm vs 2.5 mm)可提示恶性病变可能,但原文未提供诊断阈值或敏感度/特异度
- IMA相对增粗程度在所有病灶位置均大于LTA(p < 0.001),提示IMA为主导血管
- 良性病变中血管直径比值接近1,无侧别不对称,可作为对照特征
临床应用与阅片要点
- 阅片时可在早期增强动脉期轴位图像上对比两侧IMA及LTA直径,观察是否存在病灶侧优势增粗,有助于辅助提示恶性病变
- 同样适用于外侧、内侧及中央位置的病灶,IMA增粗在各类位置均较明显
- 需注意此征象不应用于预测肿瘤侵袭性或淋巴结状态,避免过度解读;测量时应由不同年资医生独立进行以减少主观性
局限性
- 回顾性研究设计,为单中心数据
- 样本量有限,且有34例良性病变作为对照,但未报告更多中心验证
- 原文明确说明该发现对预测肿瘤侵袭性或淋巴结状态价值有限
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aimed to investigate the alterations in the diameters of the internal mammary artery (IMA) and lateral thoracic artery (LTA) in newly diagnosed breast cancer patients, depending on tumor localization within the breast, using magnetic resonance imaging (MRI).
MATERIALS AND METHODS: This retrospective study included a total of 197 patients with breast MRI examinations available in the institutional database, comprising 163 patients with newly diagnosed, histopathologically confirmed breast cancer and 34 patients with benign breast lesions serving as the control group. Lesion-side and contralateral vessel diameters and their expansion ratios were analyzed according to intramammary lesion localization and clinicopathological factors. Lesion localization was categorized as lateral, medial, or central. IMA and LTA diameters were measured on original early post-contrast arterial-phase axial images (2nd-3rd dynamic series). All measurements were independently performed by two radiologists with different levels of experience (a senior breast radiologist and a 5th-year resident), blinded to each other's results.
RESULTS: In the malignant group, the median lesion-side IMA diameter was significantly larger than that of the contralateral side (3.4 mm [2.6-4.4] vs. 2.5 mm [2.0-3.1]), and a similar pattern was observed for the LTA (2.3 mm [1.8-2.8] vs. 2.0 mm [1.7-2.5]). The IMA demonstrated a greater relative increase compared to the LTA across all lesion localizations (p < 0.001). In contrast, no significant side-to-side vascular asymmetry or lesion-side arterial prominence was observed in patients with benign breast lesions, with vessel diameter ratios remaining close to unity. Interobserver agreement was excellent for IMA measurements (ICC = 0.92; 95% CI, 0.88-0.95) and good-to-excellent for LTA measurements (ICC = 0.87; 95% CI, 0.82-0.91).
CONCLUSION: Both the IMA and LTA demonstrated significantly increased diameters on the lesion side in breast cancer patients. The IMA showed a consistently greater relative increase than the LTA across different intramammary lesion localizations, supporting an IMA-predominant vascular remodeling pattern associated with malignancy. Notably, this unilateral vascular enlargement pattern was not observed in patients with benign breast lesions, suggesting that this phenomenon represents a tumor-associated vascular response specific to malignant processes. However, these findings currently have limited value in predicting tumor aggressiveness or nodal status.
引用
- Özmen, Tekcan Şanlı, Şanlı, et al. Dominant Role of the Internal Mammary Artery in Breast Cancer Vascularization: A Dynamic MRI Study of Tumor-Induced Arterial Remodeling. Acad Radiol. 2026. PMID: 42532718. doi:10.1016/j.acra.2026.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。